Some Manufacturing Issues

Before being inserted in the barrier bag, the open cell foam needs preliminary pretreatment in air to remove water and the residue of the foam production process. Volatile materials are in fact used to blow the foam chemicals and remain partially trapped in the foam matrix or condense as a liquid on the foam surface after the cells have been opened. 

These data indicate the need to design the production process and equipment in such a way that the foam is exposed to air for a very short time, not exceeding a few minutes. A limited exposure is also beneficial to reduce the evacuation time of the panel, which strongly depends on the desorption rate of physisorbed water. To further minimise reabsorption of water on the foam it is advisable to process the PU in a dry or humidity-controlled area. The water content picked-up by the foam can be measured in the finished panel by means of residual gas analysis (RGA) with the mass spectrometer, as described in Section 4.4.2.2. In general, the proper pre-treatment of the foam followed by adequate handling ensures better initial insulation performance and shorter evacuation cycles which also mean higher productivity and lower costs per panel. 

The open cell foam slabs are generally easier to handle and process than powder-based core materials like precipitated silica or perlite. However, precautions have to be adopted 

Appropriate film handling and processing is also the key to produce reliable and good quality panels. 

A preliminary investigation of these effects has been carried out by Sugiyama and coauthors [21] for some laminated plastic films incorporating a 6 pm aluminium foil. 

---

Polybutene was available as Vestolen BT since 1964 from Chemische Werke Hills, who started the first industrial production in 1964 with a capacity of 3000 tpa. In 1973, Hills withdrew Vestolen BT from the market after some manufacturing issues in their polymerization plant. Independently, Mobil Oil in the US developed their own PB-1 process technology and built a small industrial plant in Taft, Lousiana, in 1968. In the early 1970 s, the plant was taken over and operated by Witco Chemical Corporation. 

The bulk of hydrauhc fluids is specified and purchased on bid. Specifications and approval fists are issued by some manufacturers of hydraulic pumps and system components that require lubrication as well as power for control signal transmission. U.S. government military specifications for hydraulic fluids are fisted ia Table 12, and ASTM tests that are applicable to hydraulic fluids iaclude the foUowiag ... 

From the applied point of view, this reaction can be used to solve some important issues (1) production of organic subproducts (e.g., methanol, carbon monoxide, oxalic acid), which can be used for synthesizing many valuable organic substances (2) manufacture of synthetic fuels or energy-storage media and (3) removal and utilization of carbon dioxide in life-support systems for closed environments of spacecraft or submarines. 

In addition to the challenges cited above, there are some special issues associated with steroid chemistry that should be noted. The steroidal impurities formed in the process are generally similar in structure to the desired product and, in some cases, co-crystallization with the product is a problem. It is, therefore, critical to limit the formation of steroidal impurities in the reactions. The structural similarity between product and impurities also creates challenges in developing assays for reaction monitoring and purity determination. Furthermore, the poor solubility of these compounds in the solvents typically used in a manufacturing process makes it very difficult to achieve practical volume productivity in process development. 

Apart from the technical details of this incident, there were some organizational issues worthy of note. Shell operates refineries and chemical plants in many locations around the world. Before the incident at Deer Park, a similar failure had occurred in a pneumatic valve manufactured by the same supplier at another Shell refinery in the Middle East. A company-wide bulletin had been issued warning of the potential for failure with this type of valve, but no follow-up action appeared to have been taken. 

A huge number of publications meanwhile have included the term micro reactors and their applications [9] and some attempts were made to maintain order in the field, e.g. by sorting from the point of design and manufacturing issues [5, 13], by a classification of unit operations [14] or by sorting of the chemical reactions performed [15]. The latter becomes more common than the others, but a generic look seems to be necessary. 

Table 37.5 identifies provides an indication of some real issues that might be encountered when outsourcing IT services. A significant investment in terms of expertise may be required to support the outsource partner, but this is hkely to be a lot cheaper and easier than having to change outsource partners because of an unacceptable level of service. This support may come directly from the pharmaceutical manufacturer s own staff or through a third-party consultancy. 

Mineria e industrias, 1911-. Annual mining and manufacturing statistics. Title varies. Some years, including those from 1940 on, issued as two separate volumes. Some years issued as one or two volumes of the Anuario estadistico. Latest Mineria, ano 1946, published 1949 Industrias, ano 1944, published 1947. 

Consumer Reports analyzed 12 echinacea products in the March 1999 issue, using a standard set by industry. Although the standard some manufacturers use is 4% phenolic compounds (caffeoyl-tartaric acid, chlorogenic acid, cichoric acid, and echinacoside), only three products, Vita-Smart by American Fare , One-A-Day Cold Season by Bayer, and Echinex by Sunsource approached this standard at 4.5%, 4%, and 3.9%, respectively. There was also variation among different bottles of the same brand (Anonymous, 1999). 

A hyperthermic reaction has been reported in some animals given tranylcypromine or nialamide with procyclidine or benzatropine. It was considered that this might be due to an exaggerated dopamine response. However, there do not appear to be any reports of such an interaction occurring clinically. Nevertheless, some manufacturers of irreversible non-selective MAOIs and antimuscarinics issue cautions about the possibility of increased effects of antimuscarinics when given with MAOIs. This is presumably because, in theory, inhibition of drug-metabolising enzymes by MAOIs may possibly enhance the effects of antimuscarinics. 

The status of this interaction is currently controversial. Some consider that alendronate should not be given to patients receiving NSAIDs, while others urge caution in their use together. However, some consider that there is no evidence that alendronate adds to the known gastrointestinal toxicity of NSAIDs, and the manufacturer issues no caution about the concurrent use of NSAIDs. Until further evidence is available, it would seem sensible to monitor the concurrent use of alendronate and NSAIDs carefully. 

For example, some manufacturers occasionally attend to faults at a rate which is unsatisfactory to their customers. This can lead healthcare organisations to overestimate risk in an attempt to bring their issues to the front of the queue. Other healthcare organisations competing for fixes have no option but to over-prioritise their issues and a highly toxic situation results. The manufacturer is no longer able to realistically see the wood for the trees once every fault is assigned maximum... 

---